Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Alcohol Clin Exp Res. 2016 Apr 18;40(6):1312–1320. doi: 10.1111/acer.13064

Table 2.

Arrival Measures and Infusion BrAC levels

Ivermectin Placebo
Arrival Measures
 BAI 1.64 (2.73) 0.45 (0.82)
 BDI 3.00 (4.22) 3.00 (4.15)
 PACS 13.82 (6.54) 12.45 (6.64)
 POMS
  Tension 0.73 (0.43) 0.79 (0.79)
  Vigor 1.64 (0.69) 1.36 (0.91)
  Negative Affect 0.55 (0.42) 0.57 (0.32)
  Positive Affect 2.54 (1.28) 2.04 (0.92)
Target BrAC (g/dl)
 Infusion
  0.02 0.022 (0.002) 0.022 (0.003)
  0.04 0.041 (0.002) 0.041 (0.013)
  0.06 0.063 (0.002) 0.062 (0.002)
  0.08 0.083 (0.002) 0.081 (0.001)
 Post-infusion
  0.06 0.057 (0.003) 0.059 (0.003)
  0.04 0.040 (0.002) 0.040 (0.003)
Time to reach target BrAC from previous timepoint (minutes)
 Infusion
  0.02 13 (2) 12 (2)
  0.04 18 (4) 18 (4)
  0.06 26 (4) 25 (5)
  0.08 29 (9) 28 (5)
 Post-infusion
  0.06 21 (9) 22 (6)
  0.04 55 (21) 58 (27)

Data are mean (SD)

BAI – Beck Anxiety Inventory; BDI – Beck Depression Inventory; PACS – Penn Alcohol Craving Scale; POMS – Profile of Mood States, 40 item version POMS was assessed at 9:00 AM, all other Arrival Measures were collected at 8:00 AM.